Effects of Metformin on Hepatic FFA Metabolism

NCT01729156 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes
Dyslipidemia

Interventions

DRUG: Metformin
DRUG: Placebo

Sponsor

Lars Christian Gormsen